Andreas Hochhaus Department for Hematology and Medical Oncology Jena University Hospital Biography Publications Institution JoVE Articles Andreas Hochhaus has not added a biography. If you are Andreas Hochhaus and would like to personalize this page please email our Author Liaison for assistance. Publications The Acetyltransferase GCN5 Maintains ATRA-resistance in Non-APL AML Leukemia. Nov, 2019 | Pubmed ID: 31576004 Fast and Quantitative Evaluation of Human Leukocyte Interaction with Aspergillus Fumigatus Conidia by Flow Cytometry Cytometry. Part A : the Journal of the International Society for Analytical Cytology. Mar, 2019 | Pubmed ID: 30450827 Human MAIT cells Are Rapidly Activated by Aspergillus Spp. in an APC-dependent Manner European Journal of Immunology. 10, 2018 | Pubmed ID: 30059139 Questions Arising on Phlebotomy in Polycythemia Vera: Prophylactic Measures to Reduce Thromboembolic Events Require Patient-focused Decisions Leukemia. 09, 2018 | Pubmed ID: 30042412 Targeting HSP90 Dimerization Via the C Terminus is Effective in Imatinib-resistant CML and Lacks the Heat Shock Response Blood. 07, 2018 | Pubmed ID: 29724897 Ponatinib Efficacy and Safety in Philadelphia Chromosome-positive Leukemia: Final 5-year Results of the Phase 2 PACE Trial Blood. 07, 2018 | Pubmed ID: 29567798 Managing Myeloproliferative Neoplasms Evidence Based on the ELN Treatment Recommendations 2018 Leukemia. 05, 2018 | Pubmed ID: 29515237 Overall Survival with Ponatinib Versus Allogeneic Stem Cell Transplantation in Philadelphia Chromosome-positive Leukemias with the T315I Mutation Cancer. Aug, 2017 | Pubmed ID: 28387926 Nilotinib First-line Therapy in Patients with Philadelphia Chromosome-negative/BCR-ABL-positive Chronic Myeloid Leukemia in Chronic Phase: ENEST1st Sub-analysis Journal of Cancer Research and Clinical Oncology. Jul, 2017 | Pubmed ID: 28224300 Axl Blockade by BGB324 Inhibits BCR-ABL Tyrosine Kinase Inhibitor-Sensitive and -Resistant Chronic Myeloid Leukemia Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. May, 2017 | Pubmed ID: 27856601 Chronic Persistent Parvovirus B19 Bone Marrow Infection Resulting in Transfusion-dependent Pure Red Cell Aplasia in Multiple Myeloma After Allogeneic Haematopoietic Stem Cell Transplantation and Severe Graft Versus Host Disease Hematology (Amsterdam, Netherlands). Mar, 2017 | Pubmed ID: 27311084 Impact of Dose Intensity of Ponatinib on Selected Adverse Events: Multivariate Analyses from a Pooled Population of Clinical Trial Patients Leukemia Research. 09, 2016 | Pubmed ID: 27505637 Lymphocytosis After Treatment with Dasatinib in Chronic Myeloid Leukemia: Effects on Response and Toxicity Cancer. May, 2016 | Pubmed ID: 26998677 Nilotinib in Patients with Systemic Mastocytosis: Analysis of the Phase 2, Open-label, Single-arm Nilotinib Registration Study Journal of Cancer Research and Clinical Oncology. Nov, 2015 | Pubmed ID: 26002753 [Chronic Myelogenous Leukemia] Der Internist. Apr, 2015 | Pubmed ID: 25860113 Causes of Resistance and Treatment Choices of Second- and Third-line Treatment in Chronic Myelogenous Leukemia Patients Annals of Hematology. Apr, 2015 | Pubmed ID: 25814079 Adjuvant Therapy Sparing in Rectal Cancer Achieving Complete Response After Chemoradiation World Journal of Gastroenterology. Nov, 2014 | Pubmed ID: 25400468 Effect of the Tyrosine Kinase Inhibitor Nilotinib in Patients with Hypereosinophilic Syndrome/chronic Eosinophilic Leukemia: Analysis of the Phase 2, Open-label, Single-arm A2101 Study Journal of Cancer Research and Clinical Oncology. Dec, 2013 | Pubmed ID: 24057647 The Development of Dasatinib As a Treatment for Chronic Myeloid Leukemia (CML): from Initial Studies to Application in Newly Diagnosed Patients Journal of Cancer Research and Clinical Oncology. Dec, 2013 | Pubmed ID: 23942795 Differential Effects of Dosing Regimen on the Safety and Efficacy of Dasatinib: Retrospective Exposure-response Analysis of a Phase III Study Clinical Pharmacology : Advances and Applications. 2013 | Pubmed ID: 23788844 Impact of NOD2 Polymorphisms on Infectious Complications Following Chemotherapy in Patients with Acute Myeloid Leukaemia Annals of Hematology. Aug, 2013 | Pubmed ID: 23558906 Nilotinib is Associated with a Reduced Incidence of BCR-ABL Mutations Vs Imatinib in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase Blood. May, 2013 | Pubmed ID: 23502220 [Tailored Management of Chronic Myeloid Leukemia] Der Internist. Feb, 2013 | Pubmed ID: 23371258 Isolated Central Nervous System Relapse of Chronic Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation BMC Blood Disorders. 2012 | Pubmed ID: 22871019 Rac2-MRC-cIII-generated ROS Cause Genomic Instability in Chronic Myeloid Leukemia Stem Cells and Primitive Progenitors Blood. May, 2012 | Pubmed ID: 22411871 Ponatinib May Overcome Resistance of FLT3-ITD Harbouring Additional Point Mutations, Notably the Previously Refractory F691I Mutation British Journal of Haematology. May, 2012 | Pubmed ID: 22409268 Imatinib and Beyond--targeting Activated Tyrosine Kinases in Myeloproliferative Disorders Onkologie. 2012 | Pubmed ID: 22286586 Educational Session: Managing Chronic Myeloid Leukemia As a Chronic Disease Hematology. American Society of Hematology. Education Program. 2011 | Pubmed ID: 22160024 [Chronic Myeloid Leukemia] Deutsche Medizinische Wochenschrift (1946). Oct, 2011 | Pubmed ID: 21960328 Impact of BCR-ABL Mutations on Patients with Chronic Myeloid Leukemia Cell Cycle (Georgetown, Tex.). Jan, 2011 | Pubmed ID: 21220945 Dasatinib-associated Major Molecular Responses in Patients with Chronic Myeloid Leukemia in Chronic Phase Following Imatinib Failure: Response Dynamics and Predictive Value Leukemia. Sep, 2009 | Pubmed ID: 19641527 Измерение фагоцитоза Aspergillus fumigatus Conidia человеческими лейкоцитами с помощью цитометрии потока Susann Hartung1,2, Christopher Rauh2, Sarah Böttcher1, Mai Thi Ngoc Hoang1,2, Susanne Jahreis1,2, Silke Rummler3, Andreas Hochhaus2, Marie von Lilienfeld-Toal1,2 1Infections in Hematology and Oncology, Leibniz Institute for Infection Biology and Natural Product Research, 2Department for Hematology and Medical Oncology, Jena University Hospital, 3Institute for Transfusion Medicine, Jena University Hospital JoVE 60397 Immunologia e infezioni
Измерение фагоцитоза Aspergillus fumigatus Conidia человеческими лейкоцитами с помощью цитометрии потока Susann Hartung1,2, Christopher Rauh2, Sarah Böttcher1, Mai Thi Ngoc Hoang1,2, Susanne Jahreis1,2, Silke Rummler3, Andreas Hochhaus2, Marie von Lilienfeld-Toal1,2 1Infections in Hematology and Oncology, Leibniz Institute for Infection Biology and Natural Product Research, 2Department for Hematology and Medical Oncology, Jena University Hospital, 3Institute for Transfusion Medicine, Jena University Hospital JoVE 60397 Immunologia e infezioni